Brochure
27 Jun 2026

Swasthya Healthcare Product List Brochure

PDF 4.0 MB

Swasthya Healthcare Product List Brochure

Content provided by our supplier

Swasthya Healthcare Private Limited

  • Country/Region:
    India
  • On CPHI since:
    2022
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)

Other Content from Swasthya Healthcare Private Limited (3)

  • Brochure USA REGISTERED PRODUCTS

    Carfilzomib Powder for Infusion 60 mg       Introduction: Anticancer medicine used to treat multiple myeloma. 
    Use: For relapsed or refractory multiple myeloma, alone or in combination with other therapies. 
    MOA: Irreversibly inhibits the 20S proteasome, causing accumulation of proteins in cancer cells and inducing apoptosis. 
    Amphotericin B Liposomal Injection 50 mg 
    Introduction: Liposomal antifungal medicine for treating severe systemic fungal infections. 
    Use: Treats invasive fungal infections, visceral leishmaniasis, and is used as empirical therapy in febrile neutropenic patients. 
    MOA: Binds to ergosterol in fungal cell membranes, forms pores, and causes fungal cell death. The liposomal formulation reduces kidney toxicity while improving targeted drug delivery.
  • Brochure SWASTHYA HEALTHCARE PRESENTATION

    Swasthya Healthcare is an integrated pharmaceutical company from India & has offices in UAE, Singapore, and Guatemala with a strong presence across Latin America, including El Salvador, Guatemala, Bolivia, and Nicaragua. We specialize in a wide range of product categories including Oncology, Antiretrovirals (ARVs), Contrast Media, and Critical Care products.

  • Brochure CONTRAST MEDIA PRESENTATION

    Swasthya Healthcare--CONTRAST MEDIA PRODUCT RANGE